Bharat Biotech said there were no issues with its Covid-19 vaccine or its certification, reacting after the World Health Organization (WHO) suspended supplies of Covaxin through United Nations agencies.
Covaxin certificates issued remain valid, as there is no impact on efficacy and safety of the vaccine, it said. Sources close to the development said the company had no further supply commitments to the WHO, and therefore, there was no suspension of any upcoming orders.
The WHO, however, asked Bharat Biotech to upgrade its production facilities, which the company will undertake now.
“It is like one was taking a sedan for